OpenFilings
Estrella Immunopharma, Inc.
Form
8-K
Report Period
2023-09-29
Date Filed
2023-10-05
Time Filed
16:56:03
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
FORM 8-K
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
AMENDED AND RESTATED BYLAWS
JOINDER TO THE ESTRELLA SERIES A PURCHASE AGREEMENT BY AND BETWEEN ESTRELLA BIOP
JOINDER TO THE ESTRELLA SERIES A PURCHASE AGREEMENT BY AND BETWEEN ESTRELLA BIOP
JOINDER TO THE ESTRELLA SERIES A PURCHASE AGREEMENT BY AND BETWEEN ESTRELLA BIOP
JOINDER TO THE ESTRELLA SERIES A PURCHASE AGREEMENT BY AND BETWEEN ESTRELLA BIOP
JOINDER TO THE ESTRELLA SERIES A PURCHASE AGREEMENT BY AND BETWEEN ESTRELLA BIOP
JOINDER TO THE ESTRELLA SERIES A PURCHASE AGREEMENT BY AND BETWEEN ESTRELLA BIOP
STOCK TRANSFER AGREEMENT BY AND AMONG CHENG LIU, JIANDONG (PETER) XU AND QIAN (V
STOCK TRANSFER AGREEMENT BY AND AMONG CHENG LIU, JIANDONG (PETER) XU AND QIAN (V
STOCK TRANSFER AGREEMENT BY AND AMONG CHENG LIU, JIANDONG (PETER) XU AND QIAN (V
FORM OF INDEMNIFICATION AGREEMENT
ESTRELLA IMMUNOPHARMA, INC. 2023 OMNIBUS INCENTIVE PLAN
UNSECURED PROMISSORY NOTE BY AND BETWEEN HONGBIN ZHANG AND ESTRELLA BIOPHARMA IN
AMENDMENT TO OFFER LETTER BY AND BETWEEN DR. CHENG LIU AND ESTRELLA BIOPHARMA, I
AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN PETER XU AND ESTRELLA BIOPHARMA
AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN VICKY YANG AND ESTRELLA BIOPHAR
EMPLOYMENT AGREEMENT BY AND BETWEEN DR. CHENG LIU AND ESTRELLA IMMUNOPHARMA, INC
EMPLOYMENT AGREEMENT BY AND BETWEEN PETER XU AND ESTRELLA IMMUNOPHARMA, INC
CODE OF BUSINESS ETHICS AND CONDUCT OF ESTRELLA IMMUNOPHARMA, INC
LIST OF SUBSIDIARIES
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF NEW ESTRELLA AS
AUDITED FINANCIAL STATEMENTS OF ESTRELLA AS OF JUNE 30, 2023 AND 2022, AND FOR T
ESTRELLA'S MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL
Filing on SEC Edgar